Posted by admin on March 29th, 2009 in Men Health
Researchers at Wayne State University have identified a new marker for prostate cancer progression that may one day lead to new treatments. Prostate cancer, one of the most prevalent non-skin cancers in America, affects one in six men. In 2008, nearly two million Americans were being treated for prostate cancer; nearly 186,000 [...]
Posted by admin on March 29th, 2009 in Medical Devices
Stuart’s new SMP40 automatic melting point apparatus incorporates the latest digital video imaging technology to detect and accurately capture the melting point of up to three samples simultaneously. Walk-away operation speeds high throughput purity testing and the SMP40’s USB connectivity facilitates increased traceability of results to meet QC requirements in manufacturing companies.
Posted by admin on March 29th, 2009 in Medical Devices
Sparton Corporation’s (NYSE:SPA) wholly-owned subsidiary, Sparton Medical Systems, Inc., produces the medical equipment that drives the CellSearch® System to measure circulating tumor cells (CTCs). The technology used to measure circulating tumor cells was ranked as the top medical innovation for 2009 at Cleveland Clinic’s Medical Innovations Summit, a leading multispecialty academic medical center. [...]
Posted by admin on March 29th, 2009 in Medical News
AP – A novel device to treat a common heart problem that can lead to stroke showed promise in testing, but not without risk, new research shows.
Posted by admin on March 29th, 2009 in Medical News
AP – Ever wonder how that bill was calculated if you had to pay to see a doctor outside your insurance network?
Posted by admin on March 29th, 2009 in Medical News
AP – Warning to weekend warriors: Swim-bike-run triathlons pose at least twice the risk of sudden death as marathons do, the first study of these competitions has found.
Posted by admin on March 29th, 2009 in Diabetes
The Agency for Healthcare Research and Quality (AHRQ) released a pair of plain-language guides for consumers and clinicians comparing the efficacy, effectiveness, and side effects of newer premixed insulin analogues to conventional insulin (human insulin) and other preparations used to control Type 2 diabetes. The consumer guide Premixed Insulin for Type 2 [...]
Posted by admin on March 29th, 2009 in Diabetes
Anthem Blue Cross and Blue Shield and Eli Lilly and Company (NYSE: LLY) have joined with five other leading health organizations in Indiana to form the Healthy Hoosiers Alliance with a goal to fill the gaps in diabetes care by addressing health care quality, safety, access and affordability.